Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112272507 | 11227250 | 7 | F | 20141217 | 20160824 | 20150630 | 20160830 | EXP | CA-ROCHE-1600977 | ROCHE | 30.57 | YR | M | Y | 0.00000 | 20160830 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112272507 | 11227250 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | 375 MG, EVERY 4 WEEKS | U | S0065E,S0066B | 103976 | 300 | MG | SOLUTION FOR INJECTION | |||||
| 112272507 | 11227250 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0065E,S0066B | 103976 | SOLUTION FOR INJECTION | |||||||
| 112272507 | 11227250 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0065E,S0066B | 103976 | SOLUTION FOR INJECTION | |||||||
| 112272507 | 11227250 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0065E,S0066B | 103976 | SOLUTION FOR INJECTION | |||||||
| 112272507 | 11227250 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0065E,S0066B | 103976 | SOLUTION FOR INJECTION | |||||||
| 112272507 | 11227250 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | UNK | U | S0065E,S0066B | 103976 | SOLUTION FOR INJECTION | |||||||
| 112272507 | 11227250 | 7 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112272507 | 11227250 | 1 | Asthma |
| 112272507 | 11227250 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112272507 | 11227250 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112272507 | 11227250 | Asthma | |
| 112272507 | 11227250 | Cough | |
| 112272507 | 11227250 | Drug ineffective | |
| 112272507 | 11227250 | Dyspnoea | |
| 112272507 | 11227250 | Ear infection | |
| 112272507 | 11227250 | Heart rate increased | |
| 112272507 | 11227250 | Lung infection | |
| 112272507 | 11227250 | Nasopharyngitis | |
| 112272507 | 11227250 | Oxygen saturation decreased | |
| 112272507 | 11227250 | Productive cough | |
| 112272507 | 11227250 | Respiratory tract congestion | |
| 112272507 | 11227250 | Rhinitis | |
| 112272507 | 11227250 | Sinus congestion | |
| 112272507 | 11227250 | Upper respiratory tract congestion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112272507 | 11227250 | 1 | 20140623 | 0 | ||
| 112272507 | 11227250 | 2 | 20141217 | 0 | ||
| 112272507 | 11227250 | 3 | 20160404 | 0 | ||
| 112272507 | 11227250 | 4 | 20160505 | 0 | ||
| 112272507 | 11227250 | 5 | 20160602 | 0 | ||
| 112272507 | 11227250 | 6 | 20160824 | 0 |